643 related articles for article (PubMed ID: 27704393)
1. Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts.
Kalaitzoglou E; Popescu I; Bunn RC; Fowlkes JL; Thrailkill KM
Curr Osteoporos Rep; 2016 Dec; 14(6):310-319. PubMed ID: 27704393
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Skeletal Health in Type 1 Diabetes.
Weber DR; Schwartz G
Curr Osteoporos Rep; 2016 Dec; 14(6):327-336. PubMed ID: 27744554
[TBL] [Abstract][Full Text] [Related]
3. Osteocyte-driven bone remodeling.
Bellido T
Calcif Tissue Int; 2014 Jan; 94(1):25-34. PubMed ID: 24002178
[TBL] [Abstract][Full Text] [Related]
4. Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption.
Sims NA; Gooi JH
Semin Cell Dev Biol; 2008 Oct; 19(5):444-51. PubMed ID: 18718546
[TBL] [Abstract][Full Text] [Related]
5. Low bone turnover and reduced angiogenesis in streptozotocin-induced osteoporotic mice.
Peng J; Hui K; Hao C; Peng Z; Gao QX; Jin Q; Lei G; Min J; Qi Z; Bo C; Dong QN; Bing ZH; Jia XY; Fu DL
Connect Tissue Res; 2016 Jul; 57(4):277-89. PubMed ID: 27028715
[TBL] [Abstract][Full Text] [Related]
6. Friend or Foe? Essential Roles of Osteoclast in Maintaining Skeletal Health.
Wang H; Yang G; Xiao Y; Luo G; Li G; Li Z
Biomed Res Int; 2020; 2020():4791786. PubMed ID: 32190665
[TBL] [Abstract][Full Text] [Related]
7. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part I of IV parts: mechanisms of calcium transfer between blood and bone and their cellular basis: morphological and kinetic approaches to bone turnover.
Parfitt AM
Metabolism; 1976 Jul; 25(7):809-44. PubMed ID: 781470
[TBL] [Abstract][Full Text] [Related]
8. The effects of mechanically loaded osteocytes and inflammation on bone remodeling in a bisphosphonate-induced environment.
George EL; Truesdell SL; Magyar AL; Saunders MM
Bone; 2019 Oct; 127():460-473. PubMed ID: 31301402
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide in type 1 diabetes-induced osteoporosis.
Jeddi S; Yousefzadeh N; Kashfi K; Ghasemi A
Biochem Pharmacol; 2022 Mar; 197():114888. PubMed ID: 34968494
[TBL] [Abstract][Full Text] [Related]
10. Changes in osteocyte density correspond with changes in osteoblast and osteoclast activity in an osteoporotic sheep model.
Zarrinkalam MR; Mulaibrahimovic A; Atkins GJ; Moore RJ
Osteoporos Int; 2012 Apr; 23(4):1329-36. PubMed ID: 21626447
[TBL] [Abstract][Full Text] [Related]
11. Bone remodeling in the context of cellular and systemic regulation: the role of osteocytes and the nervous system.
Niedźwiedzki T; Filipowska J
J Mol Endocrinol; 2015 Oct; 55(2):R23-36. PubMed ID: 26307562
[TBL] [Abstract][Full Text] [Related]
12. The osteocyte as a signaling cell.
Delgado-Calle J; Bellido T
Physiol Rev; 2022 Jan; 102(1):379-410. PubMed ID: 34337974
[TBL] [Abstract][Full Text] [Related]
13. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
[TBL] [Abstract][Full Text] [Related]
14. Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus.
Hildebrandt N; Colditz J; Dutra C; Goes P; Salbach-Hirsch J; Thiele S; Hofbauer LC; Rauner M
Sci Rep; 2021 Jan; 11(1):1920. PubMed ID: 33479403
[TBL] [Abstract][Full Text] [Related]
15. The osteoclast, bone remodelling and treatment of metabolic bone disease.
Boyce BF; Rosenberg E; de Papp AE; Duong LT
Eur J Clin Invest; 2012 Dec; 42(12):1332-41. PubMed ID: 22998735
[TBL] [Abstract][Full Text] [Related]
16. Pro-inflammatory Cytokines: Cellular and Molecular Drug Targets for Glucocorticoid-induced-osteoporosis via Osteocyte.
Wang T; Yu X; He C
Curr Drug Targets; 2019; 20(1):1-15. PubMed ID: 29618305
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-13 is required for osteocytic perilacunar remodeling and maintains bone fracture resistance.
Tang SY; Herber RP; Ho SP; Alliston T
J Bone Miner Res; 2012 Sep; 27(9):1936-50. PubMed ID: 22549931
[TBL] [Abstract][Full Text] [Related]
18. Zoledronate promotes bone formation by blocking osteocyte-osteoblast communication during bone defect healing.
Cui P; Liu H; Sun J; Amizuka N; Sun Q; Li M
Histol Histopathol; 2018 Jan; 33(1):89-99. PubMed ID: 28345127
[TBL] [Abstract][Full Text] [Related]
19. Extracellular matrix networks in bone remodeling.
Alford AI; Kozloff KM; Hankenson KD
Int J Biochem Cell Biol; 2015 Aug; 65():20-31. PubMed ID: 25997875
[TBL] [Abstract][Full Text] [Related]
20. [Stress and cell communication between bone cells].
Nakashima T
Clin Calcium; 2013 Nov; 23(11):1595-603. PubMed ID: 24162599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
